HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases

BioMed Research International - United States
doi 10.1155/2016/8797206
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System

Scientific Reports
Multidisciplinary
2020English

Cystatins, Cysteine Peptidase Inhibitors, as Regulators of Immune Cell Cytotoxicity

Periodicum Biologorum
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2017English

Tolerogenic Dendritic Cells for Therapy of Immune-Mediated Inflammatory Diseases

2012English

Anakinra Therapy for Non-Cancer Inflammatory Diseases

Frontiers in Pharmacology
Pharmacology
2018English

Thailandepsins Are New Small Molecule Class I HDAC Inhibitors With Potent Cytotoxic Activity in Ovarian Cancer Cells: A Preclinical Study of Epigenetic Ovarian Cancer Therapy

Journal of Ovarian Research
GynecologyOncologyObstetrics
2012English

New and Emerging HDAC Inhibitors for Cancer Treatment

Journal of Clinical Investigation
Medicine
2014English

HDAC Inhibitors Show Benefits in Breast Cancer

Cancer Discovery
Oncology
2011English

Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2015English

“Curcumin, the King of Spices”: Epigenetic Regulatory Mechanisms in the Prevention of Cancer, Neurological, and Inflammatory Diseases

Current Pharmacology Reports
BiochemistryDrug DiscoveryGeneticsPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy